HealthInvest Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $2.92M | Sell |
26,712
-34,100
| -56% | -$3.73M | 6.17% | 2 |
|
|
2017
Q3 | $6.57M | Sell |
60,812
-9,400
| -13% | -$1.02M | 7.67% | 5 |
|
|
2017
Q2 | $7.1M | Sell |
70,212
-15,400
| -18% | -$1.56M | 8.86% | 4 |
|
|
2017
Q1 | $7.7M | Sell |
85,612
-25,500
| -23% | -$2.29M | 11.81% | 5 |
|
|
2016
Q4 | $8.47M | Sell |
111,112
-7,500
| -6% | -$571K | 7.8% | 4 |
|
|
2016
Q3 | $9.89M | Sell |
118,612
-31,000
| -21% | -$2.58M | 7.36% | 5 |
|
|
2016
Q2 | $12.3M | Sell |
149,612
-28,695
| -16% | -$2.37M | 5.66% | 11 |
|
|
2016
Q1 | $13.5M | Sell |
178,307
-4,400
| -2% | -$334K | 6.34% | 7 |
|
|
2015
Q4 | $14.7M | Sell |
182,707
-157,613
| -46% | -$12.7M | 6.91% | 8 |
|
|
2015
Q3 | $21.6M | Buy |
340,320
+100,000
| +42% | +$6.35M | 12.78% | 4 |
|
|
2015
Q2 | $16.9M | Buy |
240,320
+96,000
| +67% | +$6.75M | 8.64% | 7 |
|
|
2015
Q1 | $11.4M | Sell |
144,320
-17,000
| -11% | -$1.35M | 7.93% | 9 |
|
|
2014
Q4 | $10.3M | Hold |
161,320
| – | – | 8.49% | 4 |
|
|
2014
Q3 | $9.64M | Sell |
161,320
-116,693
| -42% | -$6.97M | 7.03% | 6 |
|
|
2014
Q2 | $14.9M | Buy |
278,013
+63,000
| +29% | +$3.37M | 8.38% | 4 |
|
|
2014
Q1 | $13M | Sell |
215,013
-3,887
| -2% | -$235K | 9.25% | 1 |
|
|
2013
Q4 | $11.6M | Buy |
+218,900
| New | +$11.6M | 11.55% | 2 |
|